We are live on
!
Find out more
IG
ING Group Portfolio holdings
AUM
$16.4B
1-Year Est. Return
34.6%
This Fund
S&P 500
This Quarter
Est. Return
-3.56%
1 Year Est. Return
+34.6%
3 Year Est. Return
+110.09%
5 Year Est. Return
+144.23%
10 Year Est. Return
+546.1%
AUM
$8.02B
AUM Growth
-$8.6B
(-52%)
Cap. Flow
-$7.92B
Cap. Flow
% of AUM
-98.69%
Top 10 Holdings %
Top 10 Hldgs %
46.8%
Holding
766
New
124
Increased
110
Reduced
250
Closed
238
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Air Products & Chemicals
APD
|
+$602M |
| 2 |
Mondelez International
MDLZ
|
+$350M |
| 3 |
ETP
Energy Transfer Partners L.p.
ETP
|
+$196M |
| 4 |
Enterprise Products Partners
EPD
|
+$182M |
| 5 |
Enbridge
ENB
|
+$121M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$533M |
| 2 |
Apple
AAPL
|
+$312M |
| 3 |
Bank of America
BAC
|
+$301M |
| 4 |
Microsoft
MSFT
|
+$253M |
| 5 |
Pfizer
PFE
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 27.52% |
| 2 | Financials | 18.98% |
| 3 | Materials | 9.44% |
| 4 | Technology | 7.78% |
| 5 | Consumer Staples | 7.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
TJX Companies
TJX
$170B
| $507K | 0.01% |
12,944
-3,506
| -21% | -$127K |
|
377
iShares Biotechnology ETF
IBB
$9.35B
| $500K | 0.01% |
5,754
-8,994
| -61% | -$804K |
|
378
F5
FFIV
$21.9B
| $496K | 0.01% |
+4,690
| New | +$449K |
|
379
Infosys
INFY
$43.2B
| $492K | 0.01% |
51,750
-62,624
| -55% | -$546K |
|
380
International Paper
IP
$20.1B
| $491K | 0.01% |
12,615
-48,065
| -79% | -$1.67M |
|
|
DFS
381
DELISTED
Discover Financial Services
DFS
| $484K | 0.01% |
9,504
+4,258
| +81% | +$205K |
|
382
VeriSign
VRSN
$23.8B
| $478K | 0.01% |
+5,402
| New | +$441K |
|
383
Jabil
JBL
$33.7B
| $475K | 0.01% |
24,633
| – | – |
|
|
SE
384
DELISTED
Spectra Energy Corp Wi
SE
| $472K | 0.01% |
15,429
-532,054
| -97% | -$15M |
|
385
Omnicom Group
OMC
$22.2B
| $458K | 0.01% |
5,506
-15,974
| -74% | -$1.2M |
|
|
RNF
386
DELISTED
RENTECH NITROGEN PARTNERS, L.P. INT
RNF
| $453K | 0.01% |
+39,836
| New | +$354K |
|
387
Southwest Airlines
LUV
$21.9B
| $452K | 0.01% |
10,095
-26,460
| -72% | -$1.08M |
|
388
Marathon Petroleum
MPC
$91.2B
| $451K | 0.01% |
12,126
-1,579,500
| -99% | -$60M |
|
|
TSS
389
DELISTED
Total System Services, Inc.
TSS
| $448K | 0.01% |
+9,427
| New | +$413K |
|
390
Boston Properties
BXP
$10.8B
| $446K | 0.01% |
3,513
-312,712
| -99% | -$37.1M |
|
391
Tyson Foods
TSN
$20B
| $446K | 0.01% |
6,697
-31,352
| -82% | -$1.89M |
|
392
Zimmer Biomet
ZBH
$17.3B
| $442K | 0.01% |
4,267
-131,125
| -97% | -$12.7M |
|
393
Ross Stores
ROST
$74.5B
| $439K | 0.01% |
7,586
-43,868
| -85% | -$2.44M |
|
394
Edwards Lifesciences
EW
$48.3B
| $433K | 0.01% |
14,712
-1,512,393
| -99% | -$41.7M |
|
395
WEC Energy
WEC
$37.4B
| $433K | 0.01% |
+7,206
| New | +$403K |
|
396
Eversource Energy
ES
$28.1B
| $427K | 0.01% |
7,325
-944,084
| -99% | -$51.5M |
|
397
Tesla
TSLA
$1.2T
| $427K | 0.01% |
27,855
-309,060
| -92% | -$4.07M |
|
398
Roper Technologies
ROP
$35.8B
| $421K | 0.01% |
2,303
+1,028
| +81% | +$177K |
|
399
NOV
NOV
$7.22B
| $419K | 0.01% |
+13,474
| New | +$412K |
|
400
T. Rowe Price
TROW
$24.6B
| $418K | 0.01% |
5,695
+2,591
| +83% | +$180K |
|
Similar funds
UCFA
LCOV
DADC
CCMG
EIP
CI
AIMCA
ING Group's Q1 2016 Portfolio in Review
As of Q1 2016, ING Group held 766 positions worth $8.02B, down 52% from $16.6B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
ING Group withdrew a net $7.92B in Q1 2016, closing 238 positions and reducing 250 holdings. Its most notable exit was Pfizer, an estimated $244M position sold in full.
By sector, the portfolio is most concentrated in Energy at 28% of assets, up from 9.8% a quarter earlier, followed by Financials and Materials.
Against the trend, ING Group opened a new position in Enbridge worth $138M.
- ING Group's largest Q1 2016 buy was Enbridge: 3,553,833 shares worth $138M.
- ING Group added most to Air Products & Chemicals in Q1 2016, an estimated $602M increase.
- ING Group's biggest Q1 2016 reduction was Goldman Sachs, cutting an estimated $533M.
- ING Group fully exited Pfizer in Q1 2016, selling an estimated $244M.
- ING Group's ten largest holdings make up 47% of its $8.02B portfolio in Q1 2016.
- ING Group opened 124 new positions and closed 238 in Q1 2016.
- ING Group's portfolio value fell 52% quarter-over-quarter to $8.02B.
Based on ING Group's 13F filing for Q1 2016, filed 12 May 2016.